FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3691611000001104: Dirythmin SA 150mg tablets (AstraZeneca) 100 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25949501000001118 Dirythmin SA 150mg tablets (AstraZeneca) 100 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
54098601000001113 Dirythmin SA 150mg tablets (AstraZeneca UK Ltd) 100 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dirythmin SA 150mg tablets (AstraZeneca) 100 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Dirythmin SA 150mg tablets (AstraZeneca) 100 tablet Is a Disopyramide 150mg modified-release tablets 100 tablet true Inferred relationship Existential restriction modifier
Dirythmin SA 150mg tablets (AstraZeneca) 100 tablet Is pack of Dirythmin SA 150mg tablets (AstraZeneca) false Inferred relationship Existential restriction modifier
Dirythmin SA 150mg tablets (AstraZeneca) 100 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Dirythmin SA 150mg tablets (AstraZeneca) 100 tablet Has active ingredient Disopyramide phosphate false Inferred relationship Existential restriction modifier
Dirythmin SA 150mg tablets (AstraZeneca) 100 tablet Has active ingredient Disopyramide false Inferred relationship Existential restriction modifier
Dirythmin SA 150mg tablets (AstraZeneca) 100 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Dirythmin SA 150mg tablets (AstraZeneca) 100 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Dirythmin SA 150mg tablets (AstraZeneca) 100 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Dirythmin SA 150mg tablets (AstraZeneca) 100 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dirythmin SA 150mg tablets (AstraZeneca) 100 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Dirythmin SA 150mg tablets (AstraZeneca) 100 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Dirythmin SA 150mg tablets (AstraZeneca) 100 tablet Has AMP Dirythmin SA 150mg tablets (AstraZeneca) true Inferred relationship Existential restriction modifier
Dirythmin SA 150mg tablets (AstraZeneca) 100 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Disopyramide true Inferred relationship Existential restriction modifier
Dirythmin SA 150mg tablets (AstraZeneca) 100 tablet Has specific active ingredient Disopyramide phosphate true Inferred relationship Existential restriction modifier
Dirythmin SA 150mg tablets (AstraZeneca) 100 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Dirythmin SA 150mg tablets (AstraZeneca) 100 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Dirythmin SA 150mg tablets (AstraZeneca) 100 tablet Has basis of strength substance Disopyramide true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start